By Parsa Famili, PharmD
Attending the 84th International Pharmaceutical Federation (FIP) World Congress in Montreal, Canada, in early September was both a major professional milestone and a meaningful personal homecoming to the country where I spent the first 9 years of my life.
Representing more than 5.5 million pharmacists, pharmacy educators, and pharmaceutical scientists across the globe, FIP serves as the global voice of pharmacy in official partnership with the World Health Organization. Its annual World Congress—the international equivalent of the APhA Annual Meeting & Exposition—brings together thousands of global practitioners to drive health care delivery forward. Under this year’s theme, “One Health, One Pharmacy–Bridging Science, Practice, and Education,” the event highlighted how pharmacists can build resilient health systems and improve patient outcomes globally.
Highlights from Montreal
World Congress 2026 offered exceptional programming spanning digital health, preventive care, and global health preparedness. A standout interactive session for me was the Minor Ailments, Major Impact workshop hosted by the Ontario Pharmacists Association and the University of Waterloo, which provided practical insights into managing minor dermatological conditions in community pharmacy. Another highlight was attending a session featuring Brigid Groves, PharmD, MS, APhA vice president of professional affairs. Presenting alongside Switzerland’s pharmaSuisse, she discussed
strategies for advancing coverage of pharmacists’ services within medical benefits. As a community pharmacist, learning about international efforts to expand patient access and secure payment for clinical services directly informed my approach to advocacy and practice back home.
Beyond the educational sessions, the Exposition Hall served as a vibrant hub for global innovation, scientific poster presentations, and networking. Events like the FIP Early Career Pharmaceutical Group (ECPG) Social Night, ECPG International Night, and the American Reception allowed me to connect with colleagues across American and international delegations. A personal highlight was meeting FIP President Paul Sinclair, BPharm, and FIP CEO Dr. Catherine Duggan, PhD, BPharm.
Why new practitioners should engage with ECPG
For new practitioners looking to expand their professional horizon, the FIP ECPG is the global equivalent of the APhA New Practitioner Community. While recent graduates and students receive a 50% discount on their FIP individual membership fees, official enrollment into ECPG is completely free for those who graduated within 8 years of their first degree in pharmacy or pharmaceutical sciences.
ECPG offers invaluable career development opportunities, including:
● Structured mentorship. A 9-month program matching early career professionals with global pharmacy leaders.
● Leadership cohorts and internship opportunities. Targeted leadership training (such as LDP 2.0/3.0) and short-term remote internship roles supporting FIP initiatives.
● Grants and scholarships: Access to the FIP ECPG Innovation Research Grant, FIP Early Career Leadership Development Scholarship, travel grants, and international recognition
Stepping out of your comfort zone to engage with global pharmacy organizations provides an unmatched perspective on our profession. FIP and ECPG offer early career pharmaceutical professionals a platform to exchange ideas, build worldwide networks, and recognize that while our practice environments may differ, our primary mission of advancing patient care remains universal.
Parsa Famili, PharmD, is a district support pharmacist with CVS Pharmacy. He serves as director of the Tarrant County Pharmacy Association, as a PAC challenge leader representing the APhA Community Pharmacy Practice Community, and will serve in the 2027 APhA House of Delegates representing the New Practitioner Community. Outside of work, he enjoys traveling, reading, exploring new restaurants, and spending time with family.